Measurement properties of a patient-reported outcome measure assessing psoriasis severity: The psoriasis symptoms and signs diary

Journal of Dermatological Treatment

Volumn 27, Issue 4, 2016, Pages 322-327

  Mathias, Susan D ^a   Feldman, Steven R ^b   Crosby, Ross D ^a,c,d   Colwell, Hilary H ^a   McQuarrie, Kelly ^e   Han, Chenglong ^e  

^a Health Outcomes Solutions   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c NEUROPSYCHIATRIC RESEARCH INSTITUTE   (United States)

^d UND School of Medicine & Health Sciences Southeast Campus   (United States)

^e Janssen Global Services LLC   (United States)

Author keywords

assessment tool; minimal important difference; Psoriasis; questionnaire; reliability; validity

Indexed keywords

ADULT; ARTICLE; BODY SURFACE; CORRELATIONAL STUDY; DERMATOLOGY LIFE QUALITY INDEX; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUMERICAL RATING SCALE; OUTCOME ASSESSMENT; PATIENT REPORTED OUTCOME; PRIORITY JOURNAL; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS SYMPTOMS AND SIGNS DIARY; PSORIASIS VULGARIS; PSYCHOMETRY; RATING SCALE; SHORT FORM 36; SKIN DISEASE ASSESSMENT; PATIENT-REPORTED OUTCOME; PROCEDURES; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT REPORTED OUTCOME MEASURES; PSORIASIS; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84949198562     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2015.1114567     Document Type: Article

References (26)

1. L.H.de Arruda, A.P.De Moraes The impact of psoriasis on quality of life. Br J Dermatol. 2001;144:33–6
2. J.M.Gelfand, S.R.Feldman, R.S.Stern,. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol. 2004;51:704–8
3. V.M.Heydendael, C.A.de Borgie, P.I.Spuls,. The burden of psoriasis is not determined by disease severity only. J Invest Dermatol. 2004;9:131–5
4. M.Leino, A.Mustonen, K.Mattila,. Perceived impact of psoriasis on leisure-time activities. Eur J Dermatol. 2014;24:224–8
5. E.Martinez-Garcia, S.Arias-Santiago, I.Valenzuela-Salas,. Quality of life in persons living with psoriasis patients. J Am Acad Dermatol. 2014;71:302–7
6. S.R.Rapp, C.A.Cottrell, M.R.Leary Social coping strategies associated with quality of life decrements among psoriasis patients. Br J Dermatol. 2001;145:610–16
7. S.C.Weiss, A.B.Kimball, D.J.Liewehr,. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol. 2002;47:512–18
8. M.F.Otuki, R.C.Reis, D.Cabrini,. Patient-reported outcomes in psoriasis research and practice. Br J Dermatol. 2011;165:1361–2
9. L.B.Burke, D.L.Kennedy, P.H.Miskala,. The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval. Clin Pharmacol Ther. 2008;84:281–3
10. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009. Available from http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf. Accessed May, 2015
11. A.W.Armstrong, C.Schupp, J.Wu,. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003–2011. PLoS One. 2012;7:e52935
12. D.Globe, M.S.Bayliss, D.J.Harrison The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups. Health Qual Life Outcomes. 2009;7:62
13. M.G.Lebwohl, H.Bachelez, J.Barker,. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol. 2014;70:871–81
14. F.Sampogna, S.Tabolli, D.Abeni, on behalf of the IDIMPRoVE investigators. Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life. Acta Derm Venereol. 2012;92:299–303
15. S.Feldman, S.D.Mathias, B.Schenkel,. Development of a patient-reported outcome measure for psoriasis: the psoriasis symptoms, signs and impact questionnaire. International Society for Pharmacoeconomics and Outcomes Research annual international meeting, Montreal, Quebec, Canada, 2014
16. S.Feldman, S.D.Mathias, B.Schenkel,. Development of a patient-reported outcome measure for psoriasis: the psoriasis symptoms, signs and impact questionnaire. American Academy of Dermatology annual meeting, Denver, Colorado, 2014
17. A.Y.Finlay, G.K.Khan Dermatology life quality index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–16
18. R.D.Hays, C.D.Sherbourne, R.M.Mazel The RAND 36-item health survey 1.0. Health Econ. 1993;2:217–27
19. J.C.Nunnally Psychometric Theory. 3rd ed. New York: McGraw-Hill, 1994
20. L.Cronbach Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–333
21. K.N.Lohr, N.K.Aaronson, J.Alonso,. Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther. 1996;18:979–92
22. J.Cohen Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, New Jersey: Lawrence Erlbaum, 1988
23. G.Stucki, M.H.Liang, A.H.Fossel, J.N.Katz Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. J Clin Epidemiol. 1995;48:1369–78
24. G.H.Guyatt, C.Bombardier, P.X.Tugwell Measuring disease-specific quality of life in clinical trials. CMAJ. 1986;134:889–95
25. M.Lebwohl, K.Papp, C.Han,. Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial. Br J Dermatol. 2010;162:137–46
26. J.Schmitt, S.Rosumeck, G.Thomaschewski,. Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. Br J Dermatol. 2014;170:274–303